Plasma calcitonin and tumors.
Plasma levels of calcium, phosphorus, immunoreactive calcitonin (iCT), immunoreactive parathyroid hormone (iPTH), and carcinoembryonic antigen (CEA) were measured in patients affected by tumors of various organs: 22 breast, 41 lung, 23 kidney, 16 gastrointestinal tract, and 8 other types, iCT plasma level was elevated in 53.6% of patients with bronchogenic cancer, in 31.8% with breast cancer, in 65.3% with renal cancer, in 31.2% with gastrointestinal cancer, and in 62.5% with other tumors. Blood calcium level was increased in 6 patients suffering from lung cancer; iCT plasma level was increased in all but one of these subjects. iPTH plasma level, measured in 35 patients, was elevated only in one case, in which normo-calcemia was present. Our results demonstrate that plasma iCT is increased in a high percentage of cancer patients and that it is probably a good tumor marker. The simultaneous measurement of CEA increases the diagnostic probability of the individual marker. The incidence of laboratory findings suggestive of primary or ectopic hyperparathyroidism was very low in our series of patients.
D001798:Blood Proteins / Q000032:analysis; D002116:Calcitonin / Q000097:blood*; D002118:Calcium / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000097:blood* / Q000175:diagnosis; D010758:Phosphorus / Q000097:blood
D001798:Blood Proteins; D002272:Carcinoembryonic Antigen; D010758:Phosphorus; D002116:Calcitonin; D003404:Creatinine; D002118:Calcium